ICYMI. Weekly Stock Market Recap. July 9-13,2018


13-Jul-2018 16:16 PM



In case you missed this past week market movers and economy news. 

Monday the US stock market rallies ahead of Q3 corporate earnings reports. Dow Jones up +320.11 points, SPY +0.90%, QQQ +0.90%, IBB +0.52%

  • Cell Therapeutics Inc (CTIC)- Phase 3 did not meet primary endpoints
  • Twitter Inc (TWTR) suspends over 70 million accounts in two months: Washington Post
  • DepoMed Inc (DEPO) reaches a settlement with Purdue Pharma, Bloomberg reports

Tuesday Dow Jones second day rallies, closed up 142.12 points, SPY +0.33%, QQQ +0.07%, notable red indices IWM -0.48%, IBB -0.17%.

  • Celgene Corporation (CELG)  announces IMpassion130 study meets co-primary endpoint of PFA
  • Wynn Resorts LTD (WYNN) upgraded to Buy at Stifel, price target $207
  • Tesla Inc (TSLA) plans China plant with 500,00 vehicle capacity

Wednesday the White House will impose 10% tariffs on $200 billion Chinese-made products. Market fear China retaliate, Dow Jones dropped -219.21 points, SPY-0.71%, IWM -0.82%, IBB -0.29%.

  • Achieve Life Sciences, Inc (ACHV) advancement of cytisine development program
  • Pfizer Inc (PFE) says it will postpone price increases after discussion with Trump -CNBC
  • Papa John's International, Inc (PZZA) founder allegedly used N-word on the conference call, the stock dropped -4.84%.

Thursday the US stock market rebound back, the US economic data: Initial Jobless Claims 214k vs 226k estimated, US core CPI Index (June) 257.31 vs 257.36. The Nasdaq rises to all-time high, Dow Jones +0.91%, IBB +1.62%, QQQ +1.72%, IWM +0.45%.

  • Zogenix Inc (ZGNX) primary endpoint achieved. The #BiotechCalculator predicted right

  • Papa John's International Inc (PZZA) founder John Schnatter resigns from the board.
  • Twitter (TWTR) price target raised to $55 from $40 at Goldman Sachs
  • Galmed Pharmaceuticals Ltd (GLMD) Cantor puts $59 price target on 'undervalued' NASH play
  • Facebook (FB) record highs @ $207.08
  • Inc (AMZN) record high 1,798.00

Friday continues second-day rebound 

  • JPMorgan Chase & Co (JPM)  earnings report Q2 EPS $2.29 vs $2.22
  • Johnson & Johnson ordered to pay $4.14B unitive damages in talc cancer case
  • Zogenix Inc (ZGNX) second-day stock rallies after successful Phase 3 news. 

Contact us:

Twitter: @BiotechMoney18




Add Your Comment

Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.